Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14 USD | +8.19% | +11.38% | -35.39% |
01:04pm | Earnings Flash (SAGE) SAGE THERAPEUTICS Reports Q1 Revenue $7.9M, vs. Street Est of $5.2M | MT |
Apr. 18 | TD Cowen Cuts Sage Therapeutics Price Target to $16 From $30, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.39% | 841M | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.75% | 22.2B | |
-16.53% | 21.23B | |
-9.10% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- Sage Therapeutics : SVB Leerink Adjusts Sage Therapeutics' Price Target to to $70 from $90, Keeps Market Perform Rating